Skip to content

Clinical trials

Coronary Artery Disease trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Not applicable Country / region: Canada Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20064
20073
20083
20094
20105
20113
20125
20135
20148
20152
20164
20174
201810
20194
20202
202110
20227
20235
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Active, not recruiting11
Recruiting9
Terminated8
Unknown status7
Withdrawn3
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Heart Institute Research Corporation20
Abbott Medical Devices6
University Health Network, Toronto6
Montreal Heart Institute5
Laval University4
Sunnybrook Health Sciences Centre4
University of Calgary4
Hamilton Health Sciences Corporation3
Population Health Research Institute3
University of Saskatchewan3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease100
Myocardial Ischemia10
Heart Diseases7
Heart Failure6
Coronary Disease5
Coronary Stenosis5
Diabetes Mellitus, Type 25
Heart Valve Diseases5
Myocardial Infarction5
Acute Coronary Syndrome4

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.